PubRank

Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 32805330)

Published in Int J Cardiol on August 14, 2020

Authors

Giancarlo Scognamiglio1, Flavia Fusco2, Tara C Hankel3, Berto J Bouma3, Matthias Greutmann4, Paul Khairy5, Magalie Ladouceur6, Konstantinos Dimopoulos7, Koichiro Niwa8, Craig S Broberg9, Berta Miranda10, Werner Budts11, Judith Bouchardy12, Markus Schwerzmann13, Magdalena Lipczyńska14, Daniel Tobler15, Shane F Tsai16, Alexander C Egbe17, Jamil Aboulhosn18, Susan M Fernandes19, BreAnn Garr20, Tobias Rutz21, Atsushi Mizuno8, Anna Proietti5, Rafael Alonso-Gonzalez7, Barbara J M Mulder22, Berardo Sarubbi2, non-vitamin K antagonist oral anticoagulants for thromboembolic prevention in adult congenital heart disease (NOTE) registry Investigators

Author Affiliations

1: Adult Congenital Heart Disease Unit, Department of Cardiology, Monaldi Hospital, Naples, Italy. Electronic address: giancascognamiglio@alice.it.
2: Adult Congenital Heart Disease Unit, Department of Cardiology, Monaldi Hospital, Naples, Italy.
3: Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands.
4: Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
5: Electrophysiology Service and Adult Congenital Heart Disease Centre, Montreal Heart Institute, Université de Montréal, Montreal, Canada.
6: Adult Congenital Heart Disease Unit, Centre de Référence M3C, Hôpital Européen Georges Pompidou, Université Paris Descartes, Paris, France.
7: Adult Congenital Heart Disease Centre, Royal Brompton Hospital and Imperial College of London, London, United Kingdom.
8: Department of Cardiology, St. Luke's International Hospital, Tokyo, Japan.
9: Department of Cardiology, Oregon Health & Science University Hospital, Portland, United States of America.
10: Integrated Adult Congenital Heart Disease Unit of Vall d' Hebron-Sant Pau University Hospitals, Division of Cardiology, Vall d'Hebron Hospital, Barcelona, Spain.
11: Congenital and Structural Cardiology, University Hospitals Leuven, Department of Cardiovascular Sciences, Catholic University Leuven, Leuven, Belgium.
12: Service of Cardiology, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland; Department of Cardiology, University Hospital Geneva, Genève, Switzerland.
13: Center for Congenital Heart Disease, University Hospital Inselspital, University of Bern, Bern, Switzerland.
14: Adult Congenital Heart Center, Cardinal Wyszynski National Institute of Cardiology, Warsaw, Poland.
15: Department of Cardiology, University Hospital Basel, Basel, Switzerland.
16: Department of Cardiology, University of Nebraska Medical Centre, NE, United States of America.
17: Department of Cardiology, Mayo Clinic, Rochester, United States of America.
18: Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, LosAngeles, United States of America.
19: Adult Congenital Heart Disease Program at Stanford, Lucile Packard Children's Hospital, Stanford Health Care, Stanford School of Medicine, Palo Alto, CA, United States of America.
20: Department of Cardiology, Cincinnati Children's Hospital Medical Centre, Cincinnati, United States of America.
21: Service of Cardiology, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.
22: Department of Cardiology, Academic Medical Centre, Amsterdam, the Netherlands; Interuniversity Cardiology Institute of the Netherlands, Netherlands Heart Institute, Utrecht, the Netherlands.

Articles by these authors ⇆

A savage sequence: ST-segment elevations with pulmonary embolism. Am J Med (2014) 4.37

Letter by Murakami and Niwa regarding article, "Unknown complication of arterial switch operation: resistant hypertension induced by a strong aortic arch angulation". Circulation (2014) 1.07

Letter by Murakami et al Regarding Article, "Segmental Aortic Stiffness in Children and Young Adults With Connective Tissue Disorders: Relationships With Age, Aortic Size, Rate of Dilation, and Surgical Root Replacement". Circulation (2016) 0.95

Letter by Murakami et al Regarding Article, "Segmental Aortic Stiffening Contributes to Experimental Abdominal Aortic Aneurysm Development". Circulation (2016) 0.85

Serum alkaline phosphatase as a predictor of worsening renal function in patients with acute decompensated heart failure. J Cardiol (2015) 0.78

Additional value of the red blood cell distribution width to the Mehran risk score for predicting contrast-induced acute kidney injury in patients with ST-elevation acute myocardial infarction. J Cardiol (2014) 0.77

Hyperuricemia is an independent competing risk factor for atrial fibrillation. Int J Cardiol (2016) 0.77

Atrial Function after the Atrial Switch Operation for Transposition of the Great Arteries: Comparison with Arterial Switch and Normals by Cardiovascular Magnetic Resonance. Congenit Heart Dis (2015) 0.77

A model for predicting angiographically normal coronary arteries in survivors of out-of-hospital cardiac arrest. J Intensive Care (2015) 0.75

Black defects in severe spontaneous echo contrast teach us the protective aspect of mitral regurgitation visually. J Cardiovasc Ultrasound (2013) 0.75

The problems related with primary repair for tetralogy of Fallot, especially about transannular patch repair. Transl Pediatr (2017) 0.75

Gender-related differences in self-reported dental care in adults with congenital heart disease at increased risk of infective endocarditis. Open Heart (2017) 0.75

Phonocardiogram in adult patients with tetralogy of Fallot. J Cardiol (2014) 0.75

Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias. Int J Cardiol (2017) 0.75

The differences of advance decision making between hospitalized patients with heart failure and malignant disease. Int J Cardiol (2015) 0.75

Potential palliative care quality indicators in heart disease patients: A review of the literature. J Cardiol (2017) 0.75

Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure. J Am Coll Cardiol (2017) 0.75